May 18th 2024
Efforts among organizations aim to develop innovative vaccine candidates and advancements in the global fight against HIV.
Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine
This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Read More
HIV Prevention Plan in Namibia Shows High Prevalence of Risk Factors
December 2nd 2021Study authors from the CDC found that girls in the sub-Saharan country of Namibia are at increased risk for HIV acquisition and also experience risk factors that make them eligible for HIV infection prevention programs.
Read More
Provider Stigma Can Prevent Injection Drug Users from Receiving HIV PrEP
November 13th 2021Bias against injection drug users can inhibit them from receiving potentially lifesaving care, such as HIV pre-exposure prophylaxis (PrEP). Community-based responses like syringe service programs help combat this stigma.
Watch
Lack of Improvement in HIV Infections and Use Prevention Services Among PWID
November 8th 2021People who inject drugs (PWID) remain at risk of HIV infection, according to a recent report by the CDC, which found HIV infection and HIV-associated behaviors remained steady between 2015 and 2018.
Read More